11 stories tagged with #immunovant, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Immunovant"
RELATED TAGS
SEEKING ALPHA
Immunovant: Risk-Reward Set-Up Compelling, Initiating With A Speculative Buy
Initiate coverage of Immunovant (IMVT) with a BUY and $50 price target based on IMVT-1402’s best-in-class IgG reduction and ~$4B peak sales outlook. See more.…
INVESTING.COM — NEWS
Immunovant director Atul Pande sells $59,699 in shares
INVESTING.COM — NEWS
Form 4 Immunovant Inc For: 24 July
SEEKING ALPHA
Immunovant: Upgraded To 'Buy' Because Of IMVT-1402's Broad Potential
Immunovant's underlying bull case has now moved away from batoclimab and toward IMVT-1402. Find out why IMVT stock is upgraded to buy.…
SEEKING ALPHA
Roivant: Immunovant's Rheumatoid Arthritis Win Validates The Buy
Roivant (ROIV) Buy case: IMVT-1402 posts strong Phase 2 RA efficacy, backed by $4.3B cash runway—get key catalysts, risks & valuation now.…
STAT
STAT+: Immunovant shares surge on arthritis trial data
Trial results for Lilly's "triple-G" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout…
INVESTING.COM — NEWS
H.C. Wainwright raises Immunovant stock price target on RA data
INVESTING.COM — NEWS
Immunovant director Atul Pande sells $192,000 in shares
YAHOO FINANCE
Can a New Arthritis Drug Make Immunovant the Next Biotech Star?
YAHOO FINANCE
These Stocks Are Today’s Movers: Nvidia, Micron, Intel, Meta, Lowe’s, Target, TJX, AMC, Immunovant, and More
INVESTING.COM — NEWS